Features

Campaigns Medical journal ad spend in H1 2017: All the data in one place

Medical journal ad spend in H1 2017: All the data in one place

The top three most advertised brands were GlaxoSmithKline's Breo Ellipta, Eli Lilly's Trulicity, and Boehringer Ingelheim's Jardiance.

Careers The professional paths of 8 pharma execs

The professional paths of 8 pharma execs

The successes of these pharma execs show that there's no one path to professional bliss.

Sponsored AbelsonTaylor's Jay Carter on the key to retaining top talent

AbelsonTaylor's Jay Carter on the key to retaining top talent

Now that Facebook, Apple, and Google have set their sights on healthcare, agencies find themselves under pressure from yet another flank.

Careers Pharma marketing salaries reach new heights, up 12.7% in 2017

Pharma marketing salaries reach new heights, up 12.7% in 2017

Salaries are up — by a lot — and marketers are enthusiastic about their career prospects.

Features Read the September 2017 digital edition

Read the September 2017 digital edition

Read the September 2017 issue in its entirety, including how marketing can save clinical trials.

Pipeline Infographic | How often are drugmakers sharing clinical-trial data?

Infographic | How often are drugmakers sharing clinical-trial data?

The answer: it depends on what phase the trial is in.

Commercial Drugmakers turn to social — not TV — to market drugs to women

Drugmakers turn to social — not TV — to market drugs to women

Still, most experts characterize this year's newly approved women's health drugs as modest improvements rather than groundbreaking advances in medicine.

Commercial Top 25 women's health brands, based on U.S. sales in 2016

Top 25 women's health brands, based on U.S. sales in 2016

Amgen's Prolia tops the list, according to data compiled by EvaluatePharma.

Agencies Healthcare agencies re-evaluate tactics to retain talent

Healthcare agencies re-evaluate tactics to retain talent

The best marketers possess a mix of scientific know-how, digital dexterity, and unflappability. To keep them, agencies need to revise their thinking and tactics.

Pipeline Can marketing techniques save clinical trials?

Can marketing techniques save clinical trials?

No crucial area in pharma is more desperately in need of a fix — or more stubbornly resistant to change.